Forum Topics 4DX 4DX 34% up !!

Pinned straw:

Added 2 months ago

Wow, 4DX up 34%. PME perhaps influencing this??

mikebrisy
Added 2 months ago

@Mallers I think it is a demonstration of the market influence of the top Academic Medical Centres. Mayo Clinic is one of the most prestigious.

But it is amazing that a short term trial with no contract values can have such an influence on the share price. This looks to be sentiment on steroids. This announcement of a trial with no contract values has added $900m of shareholder value. Crazy!0

As to $PME, Mayo have full stack Visage for radiology. So, CT:VQ can be integrated into the standard PACS/DICOM integration, as a matter of course, as part of the routine CT workflow.

I don’t think that $4DX CT:VQ is currently/yet available as a Visage Module, but given the ownership stake and distribution agreement this would seem to me to be a natural step in the near term.

26

Scoonie
Added 2 months ago

mikebrisy agree. Two aspects of the announcement today I find surprising:  

  1.  The Mayo Clinic deployment was not a commercial contract but only a pilot deployment and managed to add 35% or around $750m to the stock at close. 
  2. The ASX listed Cyclopharm (ASX:CYC), is in the medium to long term is directly in the sights of the 4DX CT:VQ technology. Its share price has not completely collapsed and even went up 8% today. Admittedly on only a $40k volume.  


It's been a tough 6 weeks for most investors, but moves like the above must surely spell market mispricing and opportunity. Somewhere!

25